A. Emelyanova

Efficacy of novel antibody‐based drugs against rhinovirus infection: In vitro and in vivo results

S. Johnston, M. Edwards, N. Bartlett, 2017, Antiviral Research.

Insights into the Mechanism of Action of Highly Diluted Biologics

J. Klein-Seetharaman, A. Kovalchuk, Jean-Pierre Tafani, 2020, The Journal of Immunology.

The Role of MHC Class I and Class II Molecules in Antibacterial Immunity and Treatment of Bacterial Diseases

S. Tarasov, N. Petrova, A. Emelyanova, 2022, Antibiotics and Chemotherapy.

Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.

O. Epstein, S. Tarasov, M. Skarnovich, 2017, Antiviral therapy.

The phenomenon of released‐activity. Reply on comment on Don et al.: Dose‐dependent antiviral activity of released‐active form of antibodies to interferon‐gamma against influenza A/California/07/09(H1N1) in murine model

S. Morozov, S. Tarasov, M. Nikiforova, 2017, Journal of Medical Virology.

Dose‐dependent antiviral activity of released‐active form of antibodies to interferon‐gamma against influenza A/California/07/09(H1N1) in murine model

S. Morozov, S. Tarasov, M. Nikiforova, 2017, Journal of medical virology.